Golimumab - CaLiGraph

CaLiGraph

Property	Value
rdf:type	World Health Organization essential medicine TNF inhibitor Drug: Si owl:NamedIndividual Monoclonal antibody Therapeutic monoclonal antibody Johnson & Johnson brand Merck & Co. brand Schering-Plough brand
rdfs:label	Golimumab
owl:sameAs	dbr:Golimumab
prov:wasDerivedFrom	http://en.wikipedia.org/wiki/Category:Schering-Plough_brands http://en.wikipedia.org/wiki/Category:Johnson_&_Johnson_brands http://en.wikipedia.org/wiki/List_of_drugs:_G http://en.wikipedia.org/wiki/List_of_therapeutic_monoclonal_antibodies http://en.wikipedia.org/wiki/Psoriatic_onychodystrophy http://en.wikipedia.org/wiki/Category:World_Health_Organization_essential_medicines http://en.wikipedia.org/wiki/Antiarthritics http://en.wikipedia.org/wiki/Category:Monoclonal_antibodies http://en.wikipedia.org/wiki/Disease-modifying_antirheumatic_drug http://en.wikipedia.org/wiki/Monoclonal_antibody_therapy http://en.wikipedia.org/wiki/List_of_drugs:_Si http://en.wikipedia.org/wiki/Category:Merck_&_Co._brands http://en.wikipedia.org/wiki/Category:TNF_inhibitors http://en.wikipedia.org/wiki/Etanercept http://en.wikipedia.org/wiki/Biopharmaceutical
skos:prefLabel	Golimumab
skos:altLabel	''go''limumab Simponi golimumab golimumab-Simponi
clgo:alternativeName	Simponi, Simponi Aria
clgo:casNumber	476181-74-5
clgo:chEMBL	1201833
clgo:drugbank	DB06674
clgo:fdaUniiCode	91X1KLU43E
clgo:kegg	D04358
clgo:medlinePlus	a610010
is clgo:product of	Janssen Biotech

About: clgr:Golimumab